Correspondence re: H. Barthel et al., 3'-deoxy-3'-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003

David C P Cobben, Philip H Elsinga, Aren van Waarde, Pieter L Jager

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)8558-9; author reply 8560
JournalCancer Research
Volume63
Issue number23
Publication statusPublished - 1 Dec 2003

Keywords

  • Dideoxynucleosides
  • Drug Monitoring
  • Humans
  • Neoplasms
  • Radiopharmaceuticals
  • Tomography, Emission-Computed
  • Letter

Cite this